P3 Health Partners (PIIIW) EBIAT (2021 - 2025)

P3 Health Partners (PIIIW) has 5 years of EBIAT data on file, last reported at -$250.7 million in Q4 2025.

• For the quarter ending Q4 2025, EBIAT fell 327.64% year-over-year to -$250.7 million; the trailing twelve-month figure through Dec 2025 stood at -$346.8 million (down 44.6% YoY), and the FY2025 full-year result was -$323.1 million, down 137.84% from the prior year.
• EBIAT for Q4 2025 stood at -$250.7 million, down from -$31.6 million in the prior quarter.
• Across five years, EBIAT topped out at $564.4 million in Q4 2021 and bottomed at -$1.4 billion in Q4 2022.
• The 5-year median for EBIAT is -$46.9 million (2024), against an average of -$138.8 million.
• The widest annual swing landed in 2022, when EBIAT plunged 2965.05%; it then soared 98.91% in 2023.
• A 5-year view of EBIAT shows it stood at $564.4 million in 2021, then tumbled by 345.49% to -$1.4 billion in 2022, then soared by 88.88% to -$154.1 million in 2023, then soared by 61.97% to -$58.6 million in 2024, then sank by 327.64% to -$250.7 million in 2025.
• The last three EBIAT figures came in at -$250.7 million (Q4 2025), -$31.6 million (Q3 2025), and -$20.4 million (Q2 2025), per Business Quant data.

Peer Comparison